Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubham Pant

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical ImplicationsCamila Braganca Xavier, Pooja A Shah, Daria Yakimova, et al.
Scientific Reports|December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancerReham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
The Oncologist|June 16, 2020
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic FindingsMansoor Saleh, Philippe A Cassier, Lauriane Eberst, et al.
Cancer|December 19, 2025
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trialsFen Saj, Felicity K Namayanja, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
ESMO Open|November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trialsAndrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Mutation Research. Reviews in Mutation Research|November 21, 2018
Genetic landscape of gallbladder cancer: Global overviewRavi Mehrotra, Sonam Tulsyan, Showket Hussain, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Cancer Medicine|February 26, 2025
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World SettingLevon Demirdjian, Spyros Triantos, Kristopher Standish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical ImplicationsCamila Braganca Xavier, Pooja A Shah, Daria Yakimova, et al.
Scientific Reports|December 17, 2020
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancerReham Abdel-Wahab, Timothy A Yap, Russell Madison, et al.
The Oncologist|June 16, 2020
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic FindingsMansoor Saleh, Philippe A Cassier, Lauriane Eberst, et al.
Cancer|December 19, 2025
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trialsFen Saj, Felicity K Namayanja, Lianchun Xiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2025
Advances in Targeting HER2 across Cancer Subtypes - A Pan-tumor ApproachTaiwo Adesoye, Ecaterina E Dumbrava, Kanwal P S Raghav, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
ESMO Open|November 24, 2020
Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trialsAndrew W Hahn, Omar Alhalabi, Pavlos Msaouel, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Mutation Research. Reviews in Mutation Research|November 21, 2018
Genetic landscape of gallbladder cancer: Global overviewRavi Mehrotra, Sonam Tulsyan, Showket Hussain, et al.
Pageof 19